Rosen, leading investor counsel, encourages bioxcel therapeutics, inc. investors with losses to secure counsel before important september 5 deadline in securities class action - btai

New york , aug. 25, 2023 /prnewswire/ -- why: rosen law firm, a global investor rights law firm, reminds purchasers of securities of bioxcel therapeutics, inc. (nasdaq: btai) between december 15, 2021 and june 28, 2023, both dates inclusive (the "class period"), of the important september 5, 2023 lead plaintiff deadline. so what: if you purchased bioxcel therapeutics securities during the class period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.
BTAI Ratings Summary
BTAI Quant Ranking